Emmaus Life Sciences Stock Total Asset
EMMADelisted Stock | USD 0.13 0.00 0.00% |
Emmaus Life Sciences fundamentals help investors to digest information that contributes to Emmaus Life's financial success or failures. It also enables traders to predict the movement of Emmaus OTC Stock. The fundamental analysis module provides a way to measure Emmaus Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emmaus Life otc stock.
Emmaus |
Emmaus Life Sciences OTC Stock Total Asset Analysis
Emmaus Life's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Emmaus Life Total Asset | 56.73 M |
Most of Emmaus Life's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emmaus Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Emmaus Life Sciences has a Total Asset of 56.73 M. This is 99.25% lower than that of the Pharmaceuticals sector and 97.13% lower than that of the Health Care industry. The total asset for all United States stocks is 99.81% higher than that of the company.
Emmaus Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emmaus Life's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Emmaus Life could also be used in its relative valuation, which is a method of valuing Emmaus Life by comparing valuation metrics of similar companies.Emmaus Life is currently under evaluation in total asset category among related companies.
Emmaus Fundamentals
Return On Asset | -0.12 | ||||
Profit Margin | (1.14) % | ||||
Operating Margin | (0.65) % | ||||
Current Valuation | 49.41 M | ||||
Shares Outstanding | 49.56 M | ||||
Shares Owned By Insiders | 38.73 % | ||||
Number Of Shares Shorted | 41.22 K | ||||
Price To Earning | (1.60) X | ||||
Price To Sales | 1.06 X | ||||
Revenue | 20.61 M | ||||
Gross Profit | 17.3 M | ||||
EBITDA | (12.76 M) | ||||
Net Income | (15.95 M) | ||||
Cash And Equivalents | 982 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 4.65 M | ||||
Debt To Equity | (0.04) % | ||||
Current Ratio | 0.14 X | ||||
Book Value Per Share | (0.76) X | ||||
Cash Flow From Operations | (1.25 M) | ||||
Short Ratio | 0.48 X | ||||
Earnings Per Share | (0.18) X | ||||
Target Price | 4.0 | ||||
Number Of Employees | 58 | ||||
Beta | 1.97 | ||||
Market Capitalization | 24.28 M | ||||
Total Asset | 56.73 M | ||||
Retained Earnings | (82.78 M) | ||||
Working Capital | 1.95 M | ||||
Current Asset | 9.19 M | ||||
Current Liabilities | 7.25 M | ||||
Z Score | 1.6 | ||||
Net Asset | 56.73 M |
About Emmaus Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Emmaus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emmaus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emmaus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emmaus Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emmaus Life's short interest history, or implied volatility extrapolated from Emmaus Life options trading.
Pair Trading with Emmaus Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emmaus Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will appreciate offsetting losses from the drop in the long position's value.Moving against Emmaus OTC Stock
0.71 | VCEL | Vericel Corp Ord Downward Rally | PairCorr |
0.68 | VERA | Vera Therapeutics Financial Report 9th of May 2024 | PairCorr |
0.66 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
0.58 | DSGN | Design Therapeutics Downward Rally | PairCorr |
0.47 | DTIL | Precision BioSciences Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Emmaus Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emmaus Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emmaus Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emmaus Life Sciences to buy it.
The correlation of Emmaus Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emmaus Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emmaus Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emmaus Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Emmaus OTC Stock
If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |